ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.76
+2.41%Leverage
- Debt / equity
- -0.27x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.47x
- Debt / EBITDA
- -0.72x
- Net debt / EBITDA
- -0.49x
Liquidity & coverage
- Current ratio
- 1.98x
- Quick ratio
- 1.98x
- Cash ratio
- 1.44x
- Interest coverage
- -5.04x
- EBITDA / interest
- -4.83x
- Working capital
- $6.7M
Cash & dividend
- FCF / debt
- -2.22x
- Cash flow / debt
- -2.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026